Communicating a new Graves disease diagnosis — OSCE

Task

Counsel the girl and her mother. You have five minutes. Demonstrate an organised, empathic and accurate explanation that addresses the four questions a fellowship communication station rewards: what is happening to her body and why, what the immediate and long-term plan is, what the outlook and the options are if the tablets do not hold, and how her school, growth and future will be supported. The management framework follows the 2016 American Thyroid Association hyperthyroidism guidelines. [1]

What the family needs to hear

Open by acknowledging the fear. Palpitations, weight loss and changes to your eyes are frightening for a teenager, and the word "autoimmune" is heavy — name this directly, and reassure them that the doctors have found the cause quickly, which is the single most important thing for her future. Explain in plain language what is happening: her immune system, which normally fights infection, has made an antibody that switches her thyroid gland on and keeps it running too fast. The gland is making too much thyroid hormone, and that hormone is what is making her heart race, her hands shake, her weight fall despite eating more, her mood change and her eyes stand out. Reassure them that this is a common, treatable condition, that no one caused it, and that she will get better. [1]

Address the plan honestly but with confidence. The first medicine is a beta-blocker — a tablet that quiets the racing heart and the tremor within hours, while the second medicine starts to work. The second medicine is an antithyroid drug called carbimazole, a once-a-day tablet that stops the gland over-producing, and her blood tests will guide the dose over the coming weeks until she feels well. Be honest that this is not a short course: she will likely take it for two to three years, and even then about half of young people need further treatment because the antibody is still there. Frame that not as failure but as the nature of the disease, and reassure her that feeling well is the goal however it is achieved. [1] [6]

The two drug dangers and the eye question

Give them the single most important safety message clearly. There are two rare but serious side effects they must know: if she develops a fever, a sore throat or mouth ulcers, the medicine can have dropped her white blood cells, and she must stop the tablet and be seen the same day for a blood test; and if she develops yellowing of the skin or eyes, dark urine or abdominal pain, the medicine can have affected her liver, and again she must stop and be seen. Write this down for them. This is also why we use carbimazole rather than an older drug called propylthiouracil, which can cause liver failure in young people — a change made in children's medicine precisely to keep her safe. [9]

Address the eyes with empathy and accuracy. The prominence of her eyes is caused by the same antibody acting behind the eye, not by the hormone alone — which is why the eyes can take longer to settle than the blood tests. Reassure her that mild eye changes often improve as the thyroid is controlled, that we will measure and watch them at every visit with our eye specialist, and that the things that help are not smoking (relevant as she grows), protecting the eyes from wind and screen glare, and keeping the thyroid well controlled. Severe eye problems are uncommon in young people, but we take them seriously, and there are treatments if they arise. [10]

The definitive options and the long game

Address the radioactive-iodine and surgery question honestly. If the tablets do not hold, or if she cannot tolerate them, there are two definitive options: a single radioactive-iodine treatment that quietly stops the over-active gland, or an operation by a specialist surgeon to remove it. Both mean she would then take a once-daily thyroxine tablet for life to replace what the gland was making — a simpler regimen than years of antithyroid drugs, but a permanent one. The decision would always be shared between her, you, her paediatric endocrinologist and, for surgery, a specialist team, and there is no urgency to make it today. Steer them gently away from unsupported online "cures" by acknowledging that the desire for a quick fix is completely understandable, and by offering a trusted source and a follow-up. [1] [6]

Close by naming the team and the trajectory. Her care brings together the paediatric endocrinologist, her general paediatrician, the eye specialist, her school nurse and her general practitioner, with a single written plan and a named contact. Her growth, her puberty, her school performance and her mood will be watched alongside her blood tests, because those are the markers that she is thriving, not just that the number is normal. As she moves toward adulthood, we will plan a careful handover to an adult endocrine team so that nothing is lost. The message to leave them with is hope grounded in a clear plan: this is a chronic but very treatable disease, she will feel well again, and she will not face it alone. [6] [10]